- Question from KayD: What recent data do you have on CT versus ACT? Are the anthracyclines still recommended for all breast cancers? Dr. Slamon said to shelve it and Dr. Jones seems to say it has problems. Please comment.
- Answers - Kathy D. Miller, M.D. There was no new data presented at this meeting, so currently we have only one fairly small trial comparing the TC regimen to the AC regimen. There are rare but potentially serious side effects from the anthracyclines, but they are also one of the most effective drugs in the treatment of breast cancer and many of our most effective treatment regimens include anthracyclines or use the anthracyclines as an important part of the treatment. It's difficult in this situation to make recommendations that would be appropriate for everyone, but there are other studies going on to give us more information. Until we have the results from those studies, this will still be a long discussion between patients and their oncologists to determine what's best for them.
On Tuesday, December 15, 2009, our Ask-the-Expert Online Conference was called Updates from the 2009 San Antonio Breast Cancer Symposium. Kathy Miller, M.D. and Kristin Brill, M.D., F.A.C.S. answered your questions about the latest updates on breast cancer risk, screening techniques, treatment options, and more.
The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.
A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.